ICHTHIOL

I N S T R U C T I O N for medical use of the medicinal product ICHTHYOL

Composition:

Active substance: ichthiol;

1 suppository contains 200 mg of ichthiol;

Excipient: hard fat.

Dosage form. Rectal suppositories.

Main physicochemical properties: dark brown suppositories with the odor of ichthiol. A slight white coating on the surface of the suppository may be observed.

Pharmacotherapeutic group.

Local anti-hemorrhoidal agents. ATC code C05A X.

Pharmacological properties.

Pharmacodynamics.

Ichthammol contains approximately 10.5% sulfur in the form of organic compounds, which accounts for its antiseptic, anti-inflammatory, and analgesic properties. The anti-inflammatory effect is associated with inhibition of the release of inflammatory mediators. When administered rectally, the drug exerts an irritant effect on the mucous membrane of the rectum, thereby reflexively enhancing blood circulation in the pelvic organs, which promotes resolution of inflammation in the prostate gland in men; in the ovaries, fallopian tubes, and uterus – in women.

Pharmacokinetics.

Well absorbed from the rectum following rectal administration. Excreted with feces.

Clinical characteristics.

Indications.

In the complex treatment of inflammatory diseases of the pelvis (metritis, parametritis, salpingitis, adnexitis, oophoritis), chronic nonspecific prostatitis, and hemorrhoids.

Contraindications.

Hypersensitivity to any component of the drug.

Interaction with other medicinal products and other forms of interaction.

Interaction of the drug in the form of suppositories with other medicinal products has not been described.

Special precautions for use.

Use during pregnancy or breastfeeding.

The drug may be used if the expected benefit to the mother outweighs the potential risk to the fetus (child).

Ability to influence the speed of reaction when driving vehicles or operating other machinery.

No data available.

Dosage and Administration.

For adult use. Administer rectally, 1 suppository 1–2 times daily after a cleansing enema or after a normal bowel movement. The duration of treatment is determined individually by a physician. Usually, the treatment course lasts 7–14 days. In case of disease recurrence, repeat the treatment course.

Children.

Do not use in children.

Overdose.

Cases of overdose have not been reported.

Side effects.

Allergic reactions are possible, including itching, skin rash, swelling, redness at the site of administration.

Shelf life.

2 years.

Storage conditions.

In the original packaging at a temperature not exceeding 15 °C.

Keep out of reach of children.

Packaging.

5 suppositories per strip. 2 strips per cardboard box.

Supply category.

Over-the-counter.

Manufacturer.

JSC "Monopharm".

Manufacturer's address and location of business activity.

8, Zavodska Street, Avramivka, Uman district, Cherkasy region, 19161, Ukraine.